Drugs · acquisition-cost intelligence
betamethasone dipropionate
· ingredient betamethasoneCorticosteroids· BETAMETHASONE DIPROPIONATE .5 mg/g; BETAMETHASONE DIPROPIONATE .5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.41588
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other betamethasone products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Betamethasone Dipropionate | $0.16833 | −$0.24760 |
| Clobezin | $0.19868 | −$0.21720 |
| Betamethasone Dipropionate | $0.30015 | −$0.11570 |
| Betamethasone dipropionate | $0.45908 | +$0.04320 |
| Betamethasone Dipropionate | $0.53787 | +$0.12200 |
| betamethasone valerate | $0.57225 | +$0.15640 |
| DIPROLENE | $0.61496 | +$0.19910 |
| Betamethasone Valerate | $0.73220 | +$0.31630 |
Medicare Part D coverage · CY2026
On 325 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 53% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.